Objective:

To elucidate the role of NR1I2 in intestinal inflammation and homeostasis using murine models, with implications for therapeutic strategies.

Key Findings:

• Complete Nr1i2 knockout disrupts intestinal homeostasis and increases innate immune activation, highlighting its critical role.
• Tissue-specific deletion of Nr1i2 does not replicate the whole-body knockout phenotypes, indicating the importance of systemic NR1I2 function.
• Nr1i2 deficiency generally worsens intestinal damage in response to microbial toxins or chemical insults, emphasizing its protective role.
• Pharmacological stimulation of Nr1i2 shows protective effects in a context-sensitive manner, suggesting potential therapeutic applications.

Interpretation:

NR1I2 functions as an immune–metabolic integrator, balancing xenobiotic detoxification and innate inflammatory pathways, rather than being a straightforward anti-inflammatory regulator, which may redefine therapeutic targets.

Limitations:

• Findings are based on murine models, which may not fully translate to human conditions, limiting applicability.
• Context-specific responses may vary across different types of inflammation and injury, necessitating caution in interpretation.

Conclusion:

The study highlights the complex role of NR1I2 in intestinal inflammation and suggests avenues for targeted therapeutic approaches for inflammatory conditions, particularly in IBD.